1. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. Issue 12 (December 2018) Authors: Kasner, Scott E; Swaminathan, Balakumar; Lavados, Pablo; Sharma, Mukul; Muir, Keith; Veltkamp, Roland; Ameriso, Sebastian F; Endres, Matthias; Lutsep, Helmi; Messé, Steven R; Spence, J David; Nedeltechev, Krassen; Perera, Kanjana; Santo, Gustavo; Olavarria, Veronica; Lindgren, Arne; Bangdiwala, S... Journal: Lancet neurology Issue: Volume 17:Issue 12(2018) Page Start: 1053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The validity of rheumatoid arthritis diagnoses in Finnish biobanks. (2nd January 2023) Authors: Paltta, J; Heikkilä, H-K; Pirilä, L; Eklund, KK; Huhtakangas, J; Isomäki, P; Kaipiainen-Seppänen, O; Kristiansson, K; Havulinna, AS; Sokka-Isler, T; Palomäki, A Journal: Scandinavian journal of rheumatology Issue: Volume 52:Number 1(2023) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The validity of systemic sclerosis diagnoses in two university hospitals in Finland. (2nd January 2023) Authors: Paltta, J; Kortelainen, S; Käyrä, M; Pirilä, L; Huhtakangas, J; Palomäki, A Journal: Scandinavian journal of rheumatology Issue: Volume 52:Number 1(2023) Page Start: 84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗